To Evaluate the Response to Glucagon During Hypoglycemia

NCT00817271 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: AZD1656
DRUG: Glucagon

Sponsor

AstraZeneca